Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

ClinicalTrials.gov ID: NCT05248646

Public ClinicalTrials.gov record NCT05248646. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 5:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects With Immunoglobulin A Nephropathy.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Primary Immunoglobulin A Nephropathy

Study identification

NCT ID
NCT05248646
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
530 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 15, 2022 (Actual)
Primary completion
May 13, 2026 (Actual)
Completion
Jan 19, 2027 (Estimated)
Last update posted
Jul 14, 2026

2022 – 2027

United States locations

U.S. sites
54
U.S. states
23
U.S. cities
42
Facility City State ZIP Site status
University of Alabama at Birmingham - Site #336 Birmingham Alabama 35233 —
Mayo Clinic Arizona - Site #363 Phoenix Arizona 85054 —
University of Arkansas for Medical Sciences - Site #353 Little Rock Arkansas 72205 —
Amicis Research Center - Site #341 Granada Hills California 91344 —
University of CA San Diego - Site #351 La Jolla California 92037 —
California Institute of Renal Research - Site #371 La Mesa California 91942 —
Loma Linda University Health Care Clinical Trial Center Clinic - Site #372 Loma Linda California 92354 —
Academic Medical Research Institute - Site #333 Los Angeles California 90022 —
Kaiser Permanente - Southern California Permanente Medical Group SCPMG - LAMC - Site #325 Los Angeles California 90027 —
Stanford University - Site #370 Palo Alto California 94304 —
North America Research Institute - Site #335 San Dimas California 91773 —
University of California, San Francisco - Site #377 San Francisco California 94143 —
Colorado Kidney Care PC - Site #330 Denver Colorado 80230 —
Mayo Clinic in Florida - Site #321 Jacksonville Florida 32224 —
South Florida Research Institute - Site #323 Lauderdale Lakes Florida 33313 —
Columbus Research Group - Site #376 South Miami Florida 33143 —
Fides Clinical Research North Atlanta Kidney Specialists - Site #373 Atlanta Georgia 30342 —
Georgia Nephrology - Site #356 Lawrenceville Georgia 30046 —
University of Iowa Hospitals & Clinics - Site #359 Iowa City Iowa 52242 —
Kansas Nephrology Associates - Site #322 Wichita Kansas 67214 —
Ochsner Medical Center - Site #334 New Orleans Louisiana 70121 —
University of Maryland - Site #355 Baltimore Maryland 21201 —
MGH Harvard - Site #369 Boston Massachusetts 02114 —
Brigham and Women's Hospital, Division of Renal Medicine - Site #379 Boston Massachusetts 02115 —
Tufts Medical Center - Site #349 Boston Massachusetts 02127 —
Beth Israel Deaconess Medical Center - Site #337 Boston Massachusetts 02215 —
MGH Harvard - Site #369 Boston Massachusetts 21144 —
Brigham and Women's Hospital, Division of Renal Medicine - Site #379 Boston Massachusetts 21155 —
Tufts Medical Center - Site #349 Boston Massachusetts 21277 —
Beth Israel Deaconess Medical Center - Site #337 Boston Massachusetts 22155 —
UMASS Memorial Medical Center - Site #331 Worcester Massachusetts 01655 —
UMASS Memorial Medical Center - Site #331 Worcester Massachusetts 16555 —
St. Clair Nephrology Research - Site #320 Roseville Michigan 48066 —
University of Minnesota - Site #345 Minneapolis Minnesota 55414 —
Mayo Clinic - Rochester - Site #332 Rochester Minnesota 55905 —
University of Nebraska Medical Center - Site #347 Omaha Nebraska 68198 —
Davita Clinical Research - Las Vegas - Site #327 Las Vegas Nevada 89107 —
Northwell Health - North Shore University Hospital NSUH - Site #346 Great Neck New York 11021 —
New York University Grossman School of Medicine - Site #362 New York New York 10016 —
Jacobi Medical Center - Site #364 The Bronx New York 10461 —
The University of Cincinnati - Site #343 Cincinnati Ohio 45267 —
The Ohio State University Wexner Medical Center - Site #350 Columbus Ohio 43210 —
Rhode Island Hospital - Site #367 Providence Rhode Island 02903 —
Rhode Island Hospital - Site #367 Providence Rhode Island 29033 —
Dunes Clinical Research LLC - Site #374 Dakota Dunes South Dakota 57029 —
Research Management, Inc - Site #354 Austin Texas 78751 —
Renal Disease Research Institute - Site #378 Dallas Texas 75235 —
Baylor College of Medicine (BCM) Medical Center - Site #375 Houston Texas 77030 —
Prolato Clinical Research Center (PCRC) - Site #324 Houston Texas 77054 —
Pioneer Research Solutions, Inc. - Site #339 Houston Texas 77099 —
UT Health Science Center at San Antonio - Site #368 San Antonio Texas 78229 —
Utah Kidney Research Institute - Site #342 Salt Lake City Utah 84115 —
University of Wisconsin - Site #352 Madison Wisconsin 53717 —
Medical College of Wisconsin - Site #361 Milwaukee Wisconsin 53213 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 254 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05248646, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 14, 2026 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05248646 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →